72 related articles for article (PubMed ID: 3094470)
1. Behavioral effects of lithium on presynaptic sites of catecholaminergic neurons in the mouse.
Ushijima I; Yamada K; Furukawa T
Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):58-67. PubMed ID: 3094470
[TBL] [Abstract][Full Text] [Related]
2. Progressive augmentation of locomotor activity in mice by long-term treatment with thyrotropin releasing hormone.
Ushijima I; Yamada K; Noda Y; Furukawa T
Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):29-37. PubMed ID: 6437352
[TBL] [Abstract][Full Text] [Related]
3. Biphasic effects of thyrotropin-releasing hormone on exploratory behavior in mice.
Ushijima I; Yamada K; Furukawa T; Noda Y; Todoroki M; Inanaga K
Arch Int Pharmacodyn Ther; 1980 Oct; 247(2):257-63. PubMed ID: 6778401
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute and long-term treatments with thyrotropin-releasing hormone on locomotor activity and jumping behavior in mice.
Ushijima I; Mizuki Y; Hara T; Watanabe K; Hirano H; Yamada M; Glavin GB
Pharmacol Biochem Behav; 1986 May; 24(5):1423-8. PubMed ID: 3088609
[TBL] [Abstract][Full Text] [Related]
5. Modifications by lithium of behavioral responses to methamphetamine and tetrabenazine.
Furukawa T; Ushizima I; Ono N
Psychopharmacologia; 1975 Jun; 42(3):243-8. PubMed ID: 1161982
[TBL] [Abstract][Full Text] [Related]
6. Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats.
Dziedzicka-Wasylewska M; Rogóz Z
Pol J Pharmacol; 1997; 49(5):337-43. PubMed ID: 9566033
[TBL] [Abstract][Full Text] [Related]
7. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
Jackson DM
Arzneimittelforschung; 1975 Apr; 25(4):622-6. PubMed ID: 168908
[TBL] [Abstract][Full Text] [Related]
8. [Behavioral effects of amantadine on ambulatory activity and drinking in mice and on continuous and discrete avoidance responses in rats].
Kuribara H; Tadokoro S
Nihon Yakurigaku Zasshi; 1984 Feb; 83(2):147-58. PubMed ID: 6745805
[TBL] [Abstract][Full Text] [Related]
9. Injection of apomorphine--a test to predict individual different dopaminergic sensitivity?
Surmann A; Havemann-Reinecke U
J Neural Transm Suppl; 1995; 45():143-55. PubMed ID: 8748620
[TBL] [Abstract][Full Text] [Related]
10. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
[TBL] [Abstract][Full Text] [Related]
11. Individual differences to repeated ethanol administration may predict locomotor response to other drugs, and vice versa.
Abrahao KP; Quadros IM; Souza-Formigoni ML
Behav Brain Res; 2009 Feb; 197(2):404-10. PubMed ID: 18984011
[TBL] [Abstract][Full Text] [Related]
12. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic dietary lithium on behavioral indices of dopamine denervation supersensitivity in the rat.
Swerdlow NR; Lee D; Koob GF; Vaccarino FJ
J Pharmacol Exp Ther; 1985 Nov; 235(2):324-9. PubMed ID: 3932641
[TBL] [Abstract][Full Text] [Related]
14. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
[TBL] [Abstract][Full Text] [Related]
15. Behavioral sensitization to dopaminergic inhibitory and stimulatory effects induced by low vs. high dose apomorphine treatments: an unconventional dose and response reversal sensitization challenge test reveals sensitization mechanisms.
Braga PQ; Dias FR; Carey RJ; Carrera MP
Behav Brain Res; 2009 Dec; 204(1):169-74. PubMed ID: 19520118
[TBL] [Abstract][Full Text] [Related]
16. GABA(A) receptors mediate the attenuating effects of a 5-HT(3) receptor antagonist on methamphetamine-induced behavioral sensitization in mice.
Yoo JH; Lee HK; Kim HC; Lee SY; Jang CG
Synapse; 2010 Apr; 64(4):274-9. PubMed ID: 19953653
[TBL] [Abstract][Full Text] [Related]
17. Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons.
Engberg G; Elebring T; Nissbrandt H
J Pharmacol Exp Ther; 1991 Nov; 259(2):841-7. PubMed ID: 1658311
[TBL] [Abstract][Full Text] [Related]
18. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
[TBL] [Abstract][Full Text] [Related]
19. Effects of tetrabenazine on methamphetamine-induced hyperactivity in mice are dependent on order and time-course of administration.
Kuribara H
Pharmacol Biochem Behav; 1997 Jan; 56(1):9-14. PubMed ID: 8981603
[TBL] [Abstract][Full Text] [Related]
20. Effects of 24-hr fasting on methamphetamine- and apomorphine-induced locomotor activities, and on monoamine metabolism in mouse corpus striatum and nucleus accumbens.
Itoh T; Murai S; Nagahama H; Miyate H; Abe E; Fujiwara H; Saito Y
Pharmacol Biochem Behav; 1990 Feb; 35(2):391-6. PubMed ID: 2320647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
